The dysregulation of signal transduction caused by the overexpression or abnormal activation of a protein kinase is closely related to various diseases, including cancer.2,3) Small molecular weight kinase inhibitors and antibodies have been developed and are now approved for use as molecular-targeting agents in cancer therapy. Here, WEE1 is linked to cancer.